6 April 2023 - The public summary documents (positive recommendations and subsequent decisions not to recommend) from the December 2022 PBAC ...
29 March 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC ...
29 March 2023 - The agenda for the July 2023 PBAC meeting is now available. ...
24 March 2023 - The US FDA plans to hold at least one public meeting and release several guidances on digital ...
22 March 2023 - The EMA has published a report summarising the mid-term achievements of its regulatory science strategy to ...
17 March 2023 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2022 PBAC ...
7 March 2023 - We are now at version 4 with four revisions. ...
3 March 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2022 PBAC ...
3 March 2023 - We are now up to version 3; six revisions including two withdrawn submissions. ...
1 March 2023 - Currently available evidence is rated as promising but inconclusive to determine whether lecanemab provides a net health ...
22 February 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC ...
21 February 2023 - Independent appraisal committee voted that evidence is not adequate to demonstrate a superior net health benefit ...
20 February 2023 - The EMA has published a draft agenda for this week's CHMP meeting. ...
16 February 2023 - The ICER today released a draft evidence report assessing the comparative clinical effectiveness and value of resmetirom ...
10 February 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 27 January 2023. ...